Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,817,854
-$843,691 QoQ
Shares Held
200,077
-0.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#611
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisory Services, LLC holds $45,032,363 across 13 Drug Manufacturers - General names. PFE ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,697 | $10,431,443 | |
| 2 | JNJ |
Johnson & Johnson
|
35,778 | $9,086,538 | |
| 3 | ABBV |
AbbVie Inc.
|
35,075 | $8,826,273 | |
| 4 | PFE |
Pfizer Inc
This page
|
200,077 | $4,817,854 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,988 | $3,853,458 | |
| 6 | AMGN |
Amgen Inc
|
8,846 | $3,203,313 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,911 | $1,896,331 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,218 | $785,582 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,817,854 | 200,077 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,661,545 | 201,622 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $5,154,125 | 206,993 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,241,388 | 205,706 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,190,656 | 214,136 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,355,279 | 211,337 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,321,122 | 200,570 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,294,645 | 113,844 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,338,125 | 119,304 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,072,591 | 110,724 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,827,178 | 98,200 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,894,712 | 87,269 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,523,107 | 68,787 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,703,530 | 66,263 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,584,289 | 69,951 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $3,037,162 | 69,405 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $3,603,094 | 68,722 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $3,724,178 | 71,937 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $4,152,809 | 70,327 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,047,817 | 70,863 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,874,539 | 73,405 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,619,610 | 72,305 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,696,590 | 73,257 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,329,493 | 63,474 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,103,364 | 64,323 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,107,431 | 64,566 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||